Why United Therapeutics (UTHR) Shares Are Sliding Today [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
fourth-quarter financial results that missed revenue expectations, overshadowing an earnings beat. The biotechnology firm announced revenue of $790.2 million for the quarter, which fell short of analysts' consensus estimates that were north of $805 million. While the revenue figure marked a 7% increase from the same period in the previous year, the miss on expectations soured investor sentiment. On the other hand, the company posted adjusted earnings of $7.70 per share, which was higher than the forecasted $7.10. A closer look at product sales showed that while Tyvaso sales grew 12% year-over-year, they still did not meet projections. The mixed report, with strong profits but disappointing sales, prompted the negative market reaction. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy United Therapeutics? Access our full analysis report here, it's free What Is The Market Telling Us United T
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics (UTHR) had its price target raised by Cantor Fitzgerald from $525.00 to $625.00. They now have an "overweight" rating on the stock.MarketBeat
- Asylon Robotics Announces New Advisors, Additions to Leadership Team [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of MedicineBusiness Wire
- United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) [Seeking Alpha]Seeking Alpha
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- 3/10/26 - Form 4
- UTHR's page on the SEC website